 |
|
|
| |
Discovery of MK-4882, a Novel Inhibitor of HCV NS5a with an Attractive Pre-clinical Profile
|
| |
| |
Reported by Jules Levin AASLD Nov 6-9 2011 San Francisco, CA
Steven W. Ludmerer, Christine Fandozzi, Qian Huang, Stacia Kargman, Rong Liu, Peter Meinke, David B. Olsen, and Craig A. Coburn
Merck Research Laboratories, Whitehouse Station, NJ
|
| |
|
|
|
|
|
